Mangoceuticals, Inc.
MGRX
$2.49
-$0.08-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -92.06% | -94.02% | -83.37% | -99.60% | 8.21% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -38.89% | -40.43% | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -78.31% | -- | -74.81% | -- | -- |
| Total Current Assets | -90.95% | -92.25% | -82.88% | -97.65% | 20.27% |
|
|
|||||
| Total Current Assets | -90.95% | -92.25% | -82.88% | -97.65% | 20.27% |
| Net Property, Plant & Equipment | -15.46% | -16.15% | -16.73% | -29.43% | -26.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -808.88% | -708.88% | 0.00% | -- |
| Total Assets | 1,362.74% | 827.11% | 362.23% | -92.68% | 4.73% |
|
|
|||||
| Total Accounts Payable | 494.82% | 746.24% | 452.00% | 3,312.01% | 317.80% |
| Total Accrued Expenses | -- | -31.71% | -22.95% | 86.36% | 144.44% |
| Short-term Debt | -- | -- | -- | -1.91% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.04% | 11.95% | 11.96% | 12.33% | 12.35% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 575.27% | 773.99% | 601.42% | 563.13% | -18.99% |
|
|
|||||
| Total Current Liabilities | 575.27% | 773.99% | 601.42% | 563.13% | -18.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -1.91% | -- |
| Capital Leases | -- | -85.03% | -69.10% | -57.90% | -49.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 416.49% | 483.09% | 379.21% | 325.50% | -29.10% |
|
|
|||||
| Common Stock & APIC | 196.50% | 215.46% | 207.23% | 50.52% | 356.42% |
| Retained Earnings | -85.31% | -107.69% | -133.02% | -197.07% | -457.01% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1,699.95% | 888.28% | 360.58% | -125.09% | 26.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,699.95% | 888.28% | 360.58% | -125.09% | 26.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,699.82% | 888.23% | 360.57% | -125.10% | 26.19% |
|
|
|||||